BPG is committed to discovery and dissemination of knowledge
This Article
  • Full Article (HTML) (70)
  • Full Article (PDF) (18)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (2570)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Scan QR Codes (HTML) series, Scan QR Codes (PDF) series, Tables (1-5) series.
Item 
Count 
PDF150
WORD106
HTML1274
Scan QR Codes (HTML)70
Scan QR Codes (PDF)18
Tables (1-5)5
 Sum=1623
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse616
Download419
 Sum=1035
May 12, 2015 (publication date) through Oct 24, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Ophthalmology
ISSN
2218-6239
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
Number Cited Articles
1
Hamid Ahmadieh, Ramin Nourinia, Ali Hafezi-Moghadam, Hamideh Sabbaghi, Shintaro Nakao, Souska Zandi, Mehdi Yaseri, Zahra Tofighi, Shadi Akbarian. Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial. British Journal of Ophthalmology 2019; 103(7): 922 doi: 10.1136/bjophthalmol-2018-312244
Write to the Help Desk
© 2004-2020 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345